These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30637947)

  • 1. Cardiovascular outcomes in patients with diabetes when initiating blood pressure lowering at baseline SBP between 130 and 140 mm Hg: A meta-analysis.
    Wang S; Djama NM; Lai Y; Li H; Liao W; Liao Y; Bin J
    J Clin Hypertens (Greenwich); 2019 Feb; 21(2):220-229. PubMed ID: 30637947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
    Brunström M; Carlberg B
    JAMA Intern Med; 2018 Jan; 178(1):28-36. PubMed ID: 29131895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis.
    Wang J; Chen Y; Xu W; Lu N; Cao J; Yu S
    PLoS One; 2019; 14(4):e0215362. PubMed ID: 30978254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
    Emdin CA; Rahimi K; Neal B; Callender T; Perkovic V; Patel A
    JAMA; 2015 Feb; 313(6):603-15. PubMed ID: 25668264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2018 Aug; 36(8):1622-1636. PubMed ID: 29847485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Intensive Blood Pressure Lowering on Cardiovascular Outcomes: A Systematic Review Prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines.
    D'Anci KE; Tipton K; Hedden-Gross A; Rouse B; Hermanson L; Fontanarosa J
    Ann Intern Med; 2020 Dec; 173(11):895-903. PubMed ID: 32866419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Death in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Yang Q; Zheng R; Wang S; Zhu J; Li M; Wang T; Zhao Z; Xu M; Lu J; Chen Y; Ning G; Wang W; Bi Y; Xu Y
    Hypertension; 2023 Aug; 80(8):1640-1653. PubMed ID: 37254768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
    Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
    Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
    Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
    Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Bangalore S; Toklu B; Gianos E; Schwartzbard A; Weintraub H; Ogedegbe G; Messerli FH
    Am J Med; 2017 Jun; 130(6):707-719.e8. PubMed ID: 28109971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
    Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the Optimal Systolic Blood Pressure for Hypertensive Patients: A Network Meta-analysis.
    Fei Y; Tsoi MF; Cheung BMY
    Can J Cardiol; 2018 Dec; 34(12):1581-1589. PubMed ID: 30414702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of antihypertensive treatment on diabetes mellitus or impaired glucose tolerance patients with blood pressure below 140/90 mm Hg: a meta-analysis].
    Geng X; Cui W; Yang XH; Xie RQ; Zhang JD; Zheng HM
    Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):875-9. PubMed ID: 23291026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.
    Bundy JD; Li C; Stuchlik P; Bu X; Kelly TN; Mills KT; He H; Chen J; Whelton PK; He J
    JAMA Cardiol; 2017 Jul; 2(7):775-781. PubMed ID: 28564682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Pressure and Cardiovascular Disease in Older Patients With Diabetes: Retrospective Cohort Study.
    Hong S; Park JH; Han K; Lee CB; Kim DS; Yu SH
    J Am Heart Assoc; 2021 Nov; 10(22):e020999. PubMed ID: 34726076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Achieved Blood Pressure on First Stroke in Uncomplicated Grade 1 Hypertension.
    Qin X; Li Y; Sun N; He M; Tang G; Yin D; Wang J; Liang M; Wang B; Huo Y; Xu X; Xu X; Hou FF
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.